Schedule 13G ownership disclosure

BENITEC BIOPHARMA INC

Security class unavailable · CUSIP: 08205P100

Event date: 2020-10-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
322,581
Percent of class
8.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-20-019063
Form type
SC 13G
Filer
Benitec Biopharma Inc.
CIK
CIK 1808898
Filed
Oct 07, 2020
Reporting period
Oct 05, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub